Surmodics is a provider of surface modification technologies for intravascular medical devices and chemical components for in vitro diagnostic (IVD) immunoassay tests and microarrays. Co. operates two reportable segments: Medical Device, which centers on Co.'s proprietary surface modification coating technologies that impart lubricity, pro-healing, biocompatibility characteristics, or drug-delivery capabilities to its customers' and its own medical devices and delivery systems; and IVD, which manufactures and sells components for IVD immunoassay and molecular tests within the diagnostic, biomedical research, and life science markets. The SRDX stock yearly return is shown above.
The yearly return on the SRDX stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2014 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the SRDX annual return calculation with any dividends reinvested as applicable (on ex-dates).
|